Core Viewpoint - Rosen Law Firm is reminding purchasers of Reckitt Benckiser Group PLC American Depositary Shares (ADSs) of a class action lawsuit with a lead plaintiff deadline of August 4, 2025 [1] Group 1: Class Action Details - The class period for the lawsuit is from January 13, 2021, to July 28, 2024, during which investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2][5] - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6] - Investors are encouraged to select qualified counsel with a successful track record in securities class actions [4] Group 2: Allegations Against Reckitt - The lawsuit alleges that Reckitt failed to warn investors that preterm infants were at an increased risk of developing necrotizing enterocolitis (NEC) from consuming its cow's milk-based formula, Enfamil [5] - It is claimed that Reckitt did not disclose the potential impact on sales of Enfamil and the company's exposure to legal claims, leading to materially false and misleading statements about its business and operations [5]